UAE End Stage Renal Disease Market Size & Outlook, 2023-2030

The end stage renal disease market in the UAE is expected to reach a projected revenue of US$ 7,389.8 million by 2030. A compound annual growth rate of 12.9% is expected of the UAE end stage renal disease market from 2024 to 2030.
Revenue, 2023 (US$M)
$3,161.1
Forecast, 2030 (US$M)
$7,389.8
CAGR, 2024 - 2030
12.9%
Report Coverage
UAE

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

UAE end stage renal disease market, 2018-2030 (US$M)

UAE end stage renal disease market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

UAE end stage renal disease market highlights

  • The UAE end stage renal disease market generated a revenue of USD 3,161.1 million in 2023 and is expected to reach USD 7,389.8 million by 2030.
  • The UAE market is expected to grow at a CAGR of 12.9% from 2024 to 2030.
  • In terms of segment, dialysis was the largest revenue generating treatment type in 2023.
  • Dialysis is the most lucrative treatment type segment registering the fastest growth during the forecast period.


End stage renal disease market data book summary

Market revenue in 2023USD 3,161.1 million
Market revenue in 2030USD 7,389.8 million
Growth rate12.9% (CAGR from 2023 to 2030)
Largest segmentDialysis
Fastest growing segmentDialysis
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationTransplant, Dialysis
Key market players worldwideNipro Corp, Fresenius SE & Co KGaA, Baxter International Inc, Medtronic PLC, B. Braun, BD, Asahi Kasei Corp, Cantel Medical, Nikkiso Co Ltd, JMS Support Japan


Other key industry trends

  • In terms of revenue, UAE accounted for 2.8% of the global end stage renal disease market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Middle East & Africa, Saudi Arabia end stage renal disease market is projected to lead the regional market in terms of revenue in 2030.
  • South Africa is the fastest growing regional market in Middle East & Africa and is projected to reach USD 7,502.5 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

End Stage Renal Disease Market Companies

Name Profile # Employees HQ Website
JMS Support Japan View profile 11-50 Tokyo, Tokyo, Japan, Asia https://jms-support.jp
Cantel Medical View profile 1001-5000 Little Falls, New Jersey, United States, North America http://www.cantelmedical.com
BD View profile 10001+ Franklin Lakes, New Jersey, United States, North America https://www.bd.com
Nikkiso Co Ltd View profile 8529 4-20-3, Ebisu, Shibuya-ku, Tokyo, Japan, 150-6022 http://www.nikkiso.co.jp
Nipro Corp View profile 39713 3-9-3 Honjo-Nishi Kita-ku, Osaka, Japan, 531-8510 http://www.nipro.co.jp
B. Braun View profile 10001+ Chapeltown, Sheffield, United Kingdom, Europe https://www.bbraun.co.uk
Asahi Kasei Corp View profile 48897 1-105 Kanda Jinbocho, Chiyoda-ku, Tokyo, Japan, 101-8101 http://www.asahi-kasei.co.jp
Fresenius SE & Co KGaA View profile 193865 Else-Kroener-Strasse 1, Bad Homburg, HE, Germany, 61352 https://www.fresenius.com
Medtronic PLC View profile 95000 Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 https://www.medtronic.com
Baxter International Inc View profile 60000 One Baxter Parkway, Deerfield, IL, United States, 60015 https://www.baxter.com

UAE end stage renal disease market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to end stage renal disease market will help companies and investors design strategic landscapes.


Dialysis was the largest segment with a revenue share of 78.12% in 2023. Horizon Databook has segmented the UAE end stage renal disease market based on transplant, dialysis covering the revenue growth of each sub-segment from 2018 to 2030.


As per the National Health Survey, 27.8% of the adults in UAE are suffering from obesity. UAE is one of the top 10 countries in the world having high diabetes prevalence, around 19% of the total population are suffering from diabetes.

The Dubai Health Authority has highlighted the initiative on 14 November, World Diabetes Day, to provide quality diagnostics and treatment to the diabetic population. Thus, increasing prevalence of obesity and diabetes and government initiatives are few factors driving the market growth.

Reasons to subscribe to UAE end stage renal disease market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of UAE end stage renal disease market databook

  • Our clientele includes a mix of end stage renal disease market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the UAE end stage renal disease market , including forecasts for subscribers. This country databook contains high-level insights into UAE end stage renal disease market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

UAE end stage renal disease market size, by treatment type, 2018-2030 (US$M)

UAE End Stage Renal Disease Market Outlook Share, 2023 & 2030 (US$M)

UAE end stage renal disease market size, by treatment type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online